SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFM14A - Definitive proxy statement relating to merger or acquisition:
SEC Accession No. 0001193125-24-095515
Filing Date
2024-04-15
Accepted
2024-04-15 07:35:58
Documents
10

Document Format Files

Seq Description Document Type Size
1 DEFM14A d766260ddefm14a.htm DEFM14A 1751881
2 GRAPHIC g766260dsp1.jpg GRAPHIC 3856
3 GRAPHIC g766260g00h01.jpg GRAPHIC 24576
4 GRAPHIC g766260g00h02.jpg GRAPHIC 22227
5 GRAPHIC g766260g01a96.jpg GRAPHIC 83786
6 GRAPHIC g766260g02f85.jpg GRAPHIC 84354
7 GRAPHIC g766260g03a12.jpg GRAPHIC 26620
8 GRAPHIC g766260g03w60.jpg GRAPHIC 38852
9 GRAPHIC g766260g03y96.jpg GRAPHIC 83153
10 GRAPHIC g766260g04g04.jpg GRAPHIC 28357
  Complete submission text file 0001193125-24-095515.txt   2272808
Mailing Address 14 SCHOOLHOUSE ROAD SOMERSET NJ 08873
Business Address 14 SCHOOLHOUSE ROAD SOMERSET NJ 08873 (732) 537-6200
Catalent, Inc. (Filer) CIK: 0001596783 (see all company filings)

IRS No.: 208737688 | State of Incorp.: DE | Fiscal Year End: 0630
Type: DEFM14A | Act: 34 | File No.: 001-36587 | Film No.: 24843117
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)